Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2020
Oct. 31, 2019
ASSETS    
Cash and cash equivalents $ 6,736 $ 7,473
Trade receivables, net 44,343 45,957
Inventory 4,630 5,254
Income taxes receivable 1,602 697
Prepaid expenses and other current assets 2,694 3,378
Total current assets 60,005 62,759
Property, plant and equipment, net 304,254 307,415
Intangible assets, net 183,839 222,293
Goodwill 223,154 276,088
Other non-current assets 1,753 1,813
Deferred financing costs, net 753 997
Total assets 773,758 871,365
LIABILITIES AND STOCKHOLDERS' EQUITY    
Revolving loan 1,741 23,555
Term loans, current portion 20,888 20,888
Current portion of capital lease obligations 97 91
Accounts payable 6,587 7,408
Accrued payroll and payroll expenses 13,065 9,177
Accrued expenses and other current liabilities 18,879 28,106
Income taxes payable 1,055 1,153
Deferred consideration 0 1,708
Total current liabilities 62,312 92,086
Long term debt, net of discount for deferred financing costs 343,906 360,938
Capital lease obligations, less current portion 380 477
Deferred income taxes 68,019 69,049
Warrant liability 7,031 6,769
Total liabilities 481,648 529,319
Zero-dividend convertible perpetual preferred stock, $0.0001 par value, 2,450,980 shares issued and outstanding as of October 31, 2020 and October 31, 2019 25,000 25,000
Stockholders' equity    
Common stock, $0.0001 par value, 500,000,000 shares authorized, 56,463,992 and 58,253,220 issued and outstanding as of October 31, 2020 and October 31, 2019, respectively 6 6
Additional paid-in capital 367,681 356,227
Treasury stock (131) 0
Accumulated other comprehensive loss (606) (599)
Accumulated deficit (99,840) (38,589)
Total stockholders' equity 267,110 317,045
Total liabilities and stockholders' equity $ 773,758 $ 871,365